MaaT Pharma joins Microbiome Therapeutics Innovation Group :

MaaT Pharma joins Microbiome Therapeutics Innovation Group

MaaT Pharma, a clinical-stage biotech company focused on the development of Microbiome Ecosystem Therapies (MET) dedicated to improving survival outcomes for patients with cancer, is now a member of Microbiome Therapeutics Innovation Group (MTIG).

Related Keywords

Nikole Kimes , Microbiome Therapeutics Innovation Group , Rebiotix Inc , Ferring Company , Microba Life Sciences , Maat Pharma , Siolta Therapeutics , Genetic Analysis , Seres Therapeutics , Servatus Biopharmaceuticals , Markets Amp Regulations , Emerging Markets , Icrobiome , Dancer , Ncology , Atient Centricity ,

© 2025 Vimarsana